Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials.

Clin Kidney J · 2024 · PMC10765094 · PMID 38186871

Europe PMC DOI

hedged sentence

0.0470

closest p · 0.9× alpha

0.0470

boldest claim

The sentences

marginally significantP = .047actually significant

Meta-regression analysis showed a marginally significant trend in greater decline of hepcidin levels in RCTs with more females enrolled ( P = .047).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.